Skip to main content

Pediatrix Medical Group, Inc.

corporate_fare Company Profile

Pediatrix Medical Group, Inc.

MD·NYSE·Industrial Applications And Services·CIK 0000893949

Pediatrix Medical Group, Inc. is a leading provider of physician services, specializing in newborn, maternal-fetal, and other pediatric subspecialty care. The company operates a national network of approximately 2,295 affiliated physicians across 37 states as of December 31, 2025. This network includes 1,350 physicians who provide neonatal clinical care, primarily in hospital-based neonatal intensive care units (NICUs), for premature or medically complicated babies. Additionally, over 475 affiliated physicians offer maternal-fetal and obstetrical medical care to expectant mothers with complicated pregnancies, often in areas where the company's neonatal physicians practice. The network also features other pediatric subspecialists, with over 230 physicians providing pediatric intensive care, 220 physicians delivering hospital-based pediatric care, and 20 physicians performing pediatric surgical care. During 2024, Pediatrix completed plans to exit almost all of its affiliated office-based practices, excluding maternal-fetal medicine, and also exited its primary and urgent care service line. The company's neonatal care services involve affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians staffing and managing clinical activities at over 360 NICUs in 32 states. Pediatrix Medical Group, Inc. was incorporated in Florida in 2007.

Pediatrix Medical Group, Inc. (NYSE:MD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors MD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Shareholders Approve 8 Million New Shares for Incentive Plan, Signaling Potential Dilution
  • Pediatrix Reports Strong Q1 Earnings, Continues Share Buybacks, Announces Key Executive Transition
  • Pediatrix Medical Group Reports Strong Q1 Results, Exceeding Expectations and Reaffirming Full-Year Guidance
  • Pediatrix Medical Reaffirms 2026 Adjusted EBITDA Guidance
  • Shareholders to Vote on 8 Million Share Increase for Incentive Plan, Executive Compensation Details Disclosed

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.91B
Net Income
$165.39M
Diluted EPS
$1.94
Op. Cash Flow
$271.09M
Operating Income
$208.81M
Cash & Equivalents
$375.24M
Debt / Equity
0.00×
Net Margin
8.6%
Shares Outstanding
82.98M sh
Source: 10-K · filed 2026-02-19 · accession 0001193125-26-058074
Browse all tickers starting with M →
$24.3
52-week range · as of 2026-05-07 $11.84 – $24.99
Market cap
$2B
Volume
562.3K (0.7× avg)
3-mo avg 857.5K
Live data · 2026-06-14 03:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MD - Latest Insights

MD
May 07, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.93
Real-time Price: $24.30 info
Change: +$1.37 (+6%) info
Market Cap: $1.996B info
MD
May 05, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $24.30 info
Change: +$1.89 (+8%) info
Market Cap: $1.996B info
MD
May 05, 2026, 6:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $24.30 info
Change: +$1.89 (+8%) info
Market Cap: $1.996B info
MD
May 05, 2026, 6:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.41
Real-time Price: $24.30 info
Change: +$1.89 (+8%) info
Market Cap: $1.996B info
MD
Mar 27, 2026, 6:50 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $20.79
Real-time Price: $24.30 info
Change: +$3.51 (+17%) info
Market Cap: $1.996B info
MD
Mar 26, 2026, 4:48 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $20.98
Real-time Price: $24.30 info
Change: +$3.32 (+16%) info
Market Cap: $1.996B info
MD
Feb 19, 2026, 7:00 AM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $20.65
Real-time Price: $24.30 info
Change: +$3.65 (+18%) info
Market Cap: $1.996B info
MD
Feb 19, 2026, 6:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.65
Real-time Price: $24.30 info
Change: +$3.65 (+18%) info
Market Cap: $1.996B info